By agreement of the Company’s Board of Directors reached during the Board Meeting held on 12 September 2014, the shareholders of Natraceutical are called to attend the company’s Extraordinary General Shareholders Meeting to be held, on first call, on October 24, 2014 at 12 o’clock or, on second call, on 25th October 2014 at the same time, in the Valencia Stock Exchange, Calle Libreros 2 and 4 (Valencia)
Following the sales decline at the beginning of the year, Natraceutical stabilizes its turnover in the second quarter and protects its contribution margin
Resolutions adopted at the General Shareholders’ Meeting held on June 30, 2014
Natraceutical and Laboratorio Reig Jofre agree to merger and create the 5th largest pharmaceutical company on the Spanish stock market
Laboratorio Reig Jofre, a Spanish multinational and a leader in the European pharmaceutical sector in the formulation and development of high value-added principles, and Natraceutical, a Spanish listed company which is a leader in the French nutritional supplements market through its laboratory Forté Pharma, have formalized a protocol today for the merger of both companies, which is expected to become effective before the end of this year.